SCHEDULE OF PREVIOUSLY REPORTED CONSOLIDATED FINANCIAL STATEMENTS |
A summary of the corrections
to the impacted financial statement line items in the Company’s previously issued consolidated balance sheet and consolidated statement
of cash flows as of and for the three months ended March 31, 2024.
SCHEDULE
OF PREVIOUSLY REPORTED CONSOLIDATED FINANCIAL
STATEMENTS
Condensed Consolidated Balance Sheet- Unaudited
(in thousands)
|
|
As Previously |
|
|
Revision |
|
|
As |
|
|
|
Reported |
|
|
Adjustments |
|
|
Revised |
|
Assets |
|
|
|
|
|
|
|
|
|
|
|
|
Current Assets: |
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
93,458 |
|
|
$ |
(20,311 |
) |
|
$ |
73,147 |
|
Marketable securities |
|
$ |
- |
|
|
$ |
20,311 |
|
|
$ |
20,311 |
|
Total Current Assets |
|
$ |
197,735 |
|
|
$ |
- |
|
|
$ |
197,735 |
|
Total Assets |
|
$ |
404,495 |
|
|
$ |
- |
|
|
$ |
404,495 |
|
Condensed Consolidated Statements of Cash Flows – Unaudited
(in thousands)
|
|
As Previously |
|
|
Revision |
|
|
As |
|
|
|
Reported |
|
|
Adjustments |
|
|
Revised |
|
Cash Flows From Investing Activities: |
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from sale of marketable securities |
|
$ |
- |
|
|
$ |
3,000 |
|
|
$ |
3,000 |
|
Net Cash Used In Investing Activities |
|
$ |
(2,830 |
) |
|
$ |
2,659 |
|
|
$ |
(171 |
) |
Net Decrease In Cash and Cash Equivalents and Restricted Cash |
|
$ |
(28,235 |
) |
|
$ |
2,659 |
|
|
$ |
(25,576 |
) |
Cash and Cash Equivalents and Restricted Cash - Beginning of Period |
|
$ |
121,770 |
|
|
$ |
(22,970 |
) |
|
$ |
98,800 |
|
Cash and Cash Equivalents and Restricted Cash - End of Period |
|
$ |
93,535 |
|
|
$ |
(20,311 |
) |
|
$ |
73,224 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents and restricted cash consisted of the following: |
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
93,458 |
|
|
$ |
(20,311 |
) |
|
$ |
73,147 |
|
Restricted cash |
|
$ |
77 |
|
|
$ |
- |
|
|
$ |
77 |
|
Cash and cash equivalents
and restricted cash |
|
$ |
93,535 |
|
|
$ |
(20,311 |
) |
|
$ |
73,224 |
|
|